$AKUS Akouos, Inc. Insider Trading
Get free email notifications about insider trading in Akouos, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Akouos, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Akouos, Inc. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKUS
Company Address: 645 SUMMER STREET, SUITE 200 BOSTON 02210
Phone number: 857-245-5715
Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA.
Akouos, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2021 | AKUS | Akouos, Inc. | SATO VICKI L | Director | Option Exercise | A | 13.39 | 16,000 | 214,240 | 16,000 | |
Feb 17 2021 | AKUS | Akouos, Inc. | Minegishi Sachiyo | Chief Financial Off ... | Option Exercise | A | 17.97 | 15,000 | 269,550 | 15,000 | |
Feb 17 2021 | AKUS | Akouos, Inc. | McKenna Michael John | Chief Medical Offic ... | Option Exercise | A | 17.97 | 70,000 | 1,257,900 | 70,000 | |
Feb 17 2021 | AKUS | Akouos, Inc. | Wellman Jennifer Anne | Chief Operating Off ... | Option Exercise | A | 17.97 | 100,000 | 1,797,000 | 100,000 | |
Feb 17 2021 | AKUS | Akouos, Inc. | Robinson Gregory Scott | Chief Scientific Of ... | Option Exercise | A | 17.97 | 60,000 | 1,078,200 | 60,000 | |
Feb 17 2021 | AKUS | Akouos, Inc. | Simons Emmanuel | Chief Executive Off ... | Option Exercise | A | 17.97 | 250,000 | 4,492,500 | 250,000 | |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 111,648 | 2,009,664 | 982,453 | 1.1 M to 982.5 K (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 111,648 | 2,009,664 | 982,453 | 1.1 M to 982.5 K (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 358,352 | 6,450,336 | 3,153,331 | 3.5 M to 3.2 M (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 358,352 | 6,450,336 | 3,153,331 | 3.5 M to 3.2 M (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | 5AM Ventures V, L.P. | 10% Owner | Sell | S | 18.00 | 111,648 | 2,009,664 | 982,453 | 1.1 M to 982.5 K (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | 5AM Ventures V, L.P. | 10% Owner | Sell | S | 18.00 | 111,648 | 2,009,664 | 982,453 | 1.1 M to 982.5 K (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | 5AM Ventures V, L.P. | 10% Owner | Sell | S | 18.00 | 358,352 | 6,450,336 | 3,153,331 | 3.5 M to 3.2 M (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | 5AM Ventures V, L.P. | 10% Owner | Sell | S | 18.00 | 358,352 | 6,450,336 | 3,153,331 | 3.5 M to 3.2 M (-10.20 %) |
Oct 15 2020 | AKUS | Akouos, Inc. | Minegishi Sachiyo | CHIEF FINANCIAL OFF ... | Option Exercise | A | 22.45 | 257,780 | 5,787,161 | 257,780 |